ARCHIVES

Marijuana-Derived Drug Less Effective Than Standard

This article is from The Cancer Letter archive.

Vol. 25 No. 3 | March 29, 2002

Download PDF Visit The Full Archive

Related Articles

Perjeta, Herceptin & Docetaxel Combination Extended Survival in HER2-Positive Disease

December 28, 2012

Racial Differences In Survival Increase According To Stage

August 31, 2007

National Cancer Institute Lists Approved Clinical Trials

January 31, 2003

In Congress; GAO Says Some Yew Bark Lost In ’91, But Problems Are Being Corrected

September 11, 1992

ACS-Roosevelt Awards Go to 19 New Fellows

July 30, 1976

Reimbursement Policy By Philadelphia Blue Cross Further Explained

April 21, 1989